← FDA DRUG APPROVALS

FDA NDA · NDA020889

LOTRIMIN AF

Sponsor: SCHERING PLOUGH

APPLICATION
NDA020889
TYPE
NDA
ORIGINAL APPROVAL
1989-10-27
LATEST ACTION
2002-01-16
ROUTE
Topical
DOSAGE FORM
Lotion
MARKETING STATUS
Over-the-counter

Products

LOTRIMIN AF · ReferenceOver-the-counter
CLOTRIMAZOLE 1% · Lotion · Topical

Approval history

2002-01-16Manufacturing (CMC) · Supplement 6AP
2001-08-01Labeling · Supplement 2 · standard — Label ↗AP
2001-03-07Manufacturing (CMC) · Supplement 5AP
1999-10-04Manufacturing (CMC) · Supplement 4AP
1998-05-19Manufacturing (CMC) · Supplement 1AP
1989-10-27UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →